false 0001577916 0001577916 2024-07-12 2024-07-12
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported): July 12, 2024
Premier, Inc.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware |
|
001-36092 |
|
35-2477140 |
(State or other jurisdiction of incorporation) |
|
(Commission File Number) |
|
(I.R.S. Employer Identification No.) |
13034 Ballantyne Corporate Place
Charlotte, NC 28277
(Address of principal executive offices) (Zip Code)
(704) 357-0022
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
|
|
|
|
|
Title of each class |
|
Trading Symbol |
|
Name of each exchange on which registered |
Class A Common Stock, $0.01 Par Value |
|
PINC |
|
NASDAQ Global Select Market |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01. |
Regulation FD Disclosure |
Beginning July 15, 2024, representatives of Premier, Inc. (the “Company”) are expected to meet with investors, analysts and other stakeholders or interested parties and refer to information, in whole or part, in the Stewardship Outreach, July 2024 presentation (the “Investor Presentation”) attached to this Current Report on Form 8-K as Exhibit 99.1.
Prior to the public announcement of the Company’s fiscal 2024 financial results, currently scheduled for August 20, 2024, the Company will not comment on or update its fiscal 2024 fourth quarter or full year financial performance or the matters set forth under the caption “Fiscal 2024 Guidance” in its press release dated May 7, 2024 filed as Exhibit 99.1 to the Company’s Form 8-K filed May 8, 2024.
Pursuant to Regulation FD, the Company hereby furnishes the Investor Presentation attached as Exhibit 99.1 to this Current Report on Form 8-K, which information is incorporated into this Item 7.01 by this reference.
The information in this Current Report on Form 8-K under this Item 7.01, as well as Exhibit 99.1, shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act except as shall be expressly set forth by specific reference in such a filing. The furnishing of this report is not intended to constitute a determination or an admission by the registrant that the information contained herein or incorporated herein by reference is material or that the dissemination of the information is required by Regulation FD.
Item 9.01. |
Financial Statements and Exhibits |
(d) Exhibits
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
|
|
|
|
Premier, Inc. |
|
|
|
|
|
|
|
|
By: |
|
/s/ Michael J. Alkire |
|
|
|
|
|
|
Name: Michael J. Alkire |
|
|
|
|
|
|
Title: President and Chief Executive Officer |
Date: July 12, 2024 |
|
|
|
|
|
|
![Slide 1 Slide 1](https://www.sec.gov/Archives/edgar/data/1577916/000119312524178054/g845199ex99_1s1g1.jpg)
Stewardship Outreach July 2024 Exhibit
99.1
![Slide 2 Slide 2](https://www.sec.gov/Archives/edgar/data/1577916/000119312524178054/g845199ex99_1s2g1.jpg)
Forward-looking statements
Forward-looking statements – Statements made in this presentation that are not statements of historical or current facts, such as those related to our ability to advance our growth strategies and develop innovations for, transform and improve
healthcare, our financial position and capital deployment strategies, our ability to fund and conduct share repurchases pursuant to the existing share repurchase authorization and the potential benefits thereof (including the existing accelerated
share repurchase transaction, which could be affected by volatility or disruptions in the capital markets or other factors), the payment of dividends at current levels or at all, and the effectiveness of our executive compensation programs, are
“forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements may involve known and unknown risks, uncertainties and other factors that may cause the actual results,
performance or achievements of Premier to be materially different from historical results or from any future results or projections expressed or implied by such forward-looking statements. Accordingly, readers should not place undue reliance on any
forward-looking statements. In addition to statements that explicitly describe such risks and uncertainties, readers are urged to consider statements in the conditional or future tenses or that include terms such as “believes,”
“belief,” “expects,” “estimates,” “intends,” “remains committed to,” “anticipates” or “plans” to be uncertain and forward-looking. Forward-looking statements may
include comments as to Premier’s beliefs and expectations as to future events and trends affecting its business and are necessarily subject to risks and uncertainties, many of which are outside Premier’s control. More information on
risks and uncertainties that could affect Premier’s business, achievements, performance, financial condition and financial results is included from time to time in the “Cautionary Note Regarding Forward-Looking Statements,”
“Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” sections of Premier’s periodic and current filings with the SEC, including those sections of
Premier’s Form 10-K for the year ended June 30, 2023, and subsequent Quarterly Reports on Form 10-Q. Premier’s periodic and current filings with the SEC are made available on Premier’s website at investors.premierinc.com.
Forward-looking statements speak only as of the date they are made, and Premier undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information or future events that occur after that date,
or otherwise.
![Slide 3 Slide 3](https://www.sec.gov/Archives/edgar/data/1577916/000119312524178054/g845199ex99_1s3g1.jpg)
Through collaboration with our member
health systems, customers and other stakeholders and leveraging technology-based solutions and supply chain capabilities, we help improve the delivery of healthcare while effectively reducing costs. Premier Inc. A Purpose-Driven Healthcare
Company
![Slide 4 Slide 4](https://www.sec.gov/Archives/edgar/data/1577916/000119312524178054/g845199ex99_1s4g1.jpg)
A Highly Differentiated Business Model
DELIVERING MEANINGFUL INSIGHTS AND SOLUTIONS Strategic and collaborative member relationships built on trust Comprehensive and scalable technology and services platform powered by one of the broadest and deepest data sets in the healthcare industry
+ Healthcare providers Governments Payers Life sciences companies Suppliers Providing clinicians with timely, critical insights to help determine the best care protocols for their patients Connecting patients to necessary care faster and more
efficiently – and with less paperwork Building a smarter, more resilient and technology-enabled supply chain to ensure providers always have access to a competitive, stable and diverse market for medical supplies, pharmaceuticals, capital
equipment, business supplies and professional services SERVING Saving healthcare providers millions of dollars through automation of purchasing and payment processes
![Slide 5 Slide 5](https://www.sec.gov/Archives/edgar/data/1577916/000119312524178054/g845199ex99_1s5g1.jpg)
What We Do Best Together with our
Members, Premier Accelerates Innovation in Healthcare Network of more than 4,350 hospitals and health systems and approximately 300,000 other providers and organizations AI-enabled technology and services platform driving insights to action Billions
of data points providing unique visibility into care delivery and the supply chain, end-to-end We express solutions through technology, services and programs We scale quickly using the power of the Premier Alliance We identify innovation catalysts
![Slide 6 Slide 6](https://www.sec.gov/Archives/edgar/data/1577916/000119312524178054/g845199ex99_1s6g1.jpg)
Delivering Innovative Solutions to
Drive Growth Performance Services Supply Chain Services Large-Scale Provider Network GROUP PURCHASING ORGANIZATION Collective purchasing power designed to lower non-labor costs without sacrificing outcomes across acute and non-acute segments Supply
chain co-management and workforce enhancement capabilities Proprietary suite of AI-enabled clinical, margin and value-based care technology solutions Supply chain-focused digital invoicing and payments platform
![Slide 7 Slide 7](https://www.sec.gov/Archives/edgar/data/1577916/000119312524178054/g845199ex99_1s7g1.jpg)
Multi-lever Growth Strategy Supported
by Strong Foundation Multi-lever Growth Strategy Strengthen and build capabilities Grow and deepen relationships Create and deliver innovative solutions Expand into adjacent markets Strong, stable cash flow supports investments in growth
Comprehensive technology and services platform Innovation driven by strength of member network, diverse capabilities, robust data, acquisitions and talent Highly engaged culture
![Slide 8 Slide 8](https://www.sec.gov/Archives/edgar/data/1577916/000119312524178054/g845199ex99_1s8g1.jpg)
Experienced Leadership Team Mike
Alkire PRESIDENT AND CEO 21 years Premier, 21 years healthcare Cap Gemini Ernst & Young Leigh Anderson CHIEF OPERATING OFFICER 11 years Premier, 25+ years healthcare informatics Hospital Corporation of America, HealthTrust, GHX Craig McKasson
CHIEF ADMINISTRATIVE AND FINANCIAL OFFICER 27 years Premier, 30+ years healthcare Ernst & Young Kaycee Kalpin CHIEF MARKETING OFFICER 10 years Premier, 17 years marketing American College of Cardiology, CardioSmart Andy Brailo CHIEF COMMERCIAL
OFFICER 23 years Premier, 25+ years healthcare C.R. Bard, GHX Soumi Saha SENIOR VICE PRESIDENT OF GOVERNMENT AFFAIRS 6 years Premier, 17 years healthcare policy Academy of Managed Care Pharmacy, Kaiser Permanente, CVS/Caremark David Klatsky GENERAL
COUNSEL 8 years Premier, 30+ years healthcare McDermott, Will & Emery Crystal Climer CHIEF ACCOUNTING OFFICER 8 years Premier, 20+ year accounting BSN Medical Bruce Radcliff SENIOR VICE PRESIDENT OF SUPPLY CHAIN 15+ years healthcare provider
operations and 10+ years supply chain Advocate Aurora Health Joe Machicote CHIEF DIVERSITY AND INCLUSION OFFICER 30+ years DEI&B and human resources Erickson Living, Snyder’s-Lance, Compass Group Lisa Benna CHIEF HUMAN RESOURCES OFFICER
30+ years human resources 20+ years biotech / pharmaceuticals G1 Therapeutics, GlaxoSmithKline, Wyeth Pharmaceuticals
![Slide 9 Slide 9](https://www.sec.gov/Archives/edgar/data/1577916/000119312524178054/g845199ex99_1s9g1.jpg)
Commitment to Corporate Governance
Drives Alignment and Accountability Enhancements to Corporate Governance Board committed to ongoing refreshment and adding diversity of skills, experience and perspectives 100% of directors own PINC stock Anti-hedging and anti-pledging policies
Annual shareholder engagement program Directors are 44% diverse based on gender, race or ethnicity Board Vice Chair is female; three of five Board committee chairs are female Renomination capped at age of 72 Periodic committee membership rotation
Individual director self- and peer- assessments Limits on other public company board service (total of 4 public company boards and total of 2 public boards for NEOs of publicly traded companies) Commitment to Diversity and Refreshment Independent
Board Chair Independent key Board committees Annual review of succession planning 8 out of 9 directors are independent Director mentorship and continuing education programs Environmental, social and governance (ESG) oversight at Board level
Leadership and Oversight
![Slide 10 Slide 10](https://www.sec.gov/Archives/edgar/data/1577916/000119312524178054/g845199ex99_1s10g1.jpg)
A “Fit-for-Purpose”
Board of Directors Photo Board Member Age Board Tenure Primary Occupation Key Skills / Qualifications Independent Director Michael J. Alkire 61 3 President and CEO 30 years of operational, technology and business development leadership experience;
joined Premier in 2003 - John Bigalke 69 5 CEO of Second Half Healthcare Advisors Financial, corporate accounting, business development and leadership experiences; serving on audit committees at other public and private companies + Helen M. Boudreau
58 4 Retired: former COO of Bill & Melinda Gates Medical Research Institute Financial background with more than 20 years in the healthcare industry; serves as chair of audit committees and on compensation committees for other public companies;
NACD directorship certified. + Jody R. Davids 68 9 Retired: former SVP and Chief Information Officer at PepsiCo; currently serves on Paymentus’ Board of Directors Information technology, cybersecurity risk management, supply chain, logistics
and distribution and executive leadership experience + Peter S. Fine 72 11 Retired: former President and CEO, Banner Health; currently serves on Jeenie’s Board of Directors 44 years healthcare industry experience and executive leadership
experience at large healthcare system + Marc D. Miller 53 9 President and CEO, Universal Health Services 26 years healthcare industry experience and public company leadership experience + Marvin R O’Quinn 72 9 Retired: former president and
COO, CommonSpirit Health 41 years healthcare industry experience and leadership experience serving in executive positions at large healthcare systems + Richard J. Statuto 67 11 Retired: former President and CEO of Bon Secours Health System 35 years
healthcare industry experience and leadership experience at large healthcare systems + Ellen C. Wolf 70 11 Retired: former SVP and CFO of American Water Works Company Financial, corporate accounting, business development and leadership experience;
served on audit & compensation committees of other company boards +
![Slide 11 Slide 11](https://www.sec.gov/Archives/edgar/data/1577916/000119312524178054/g845199ex99_1s11g1.jpg)
Board Diversity 44% Diverse Board
Tenure Board Independence Age 66 years Average Age 88% Independent Engaged and Diverse Board with Critical Skillset Board candidates who represent diverse mix of skills, perspectives, talents, backgrounds and education that will enhance
decision-making process, oversee management’s execution of strategic objectives and reflect interests of stockholders are considered. Board Snapshot Board of Directors Experience and Skills Note: All figures are presented as of June 30,
2024.
![Slide 12 Slide 12](https://www.sec.gov/Archives/edgar/data/1577916/000119312524178054/g845199ex99_1s12g1.jpg)
Executive Compensation Program
Aligned with Stockholder Value Creation 27% Time-Based Restricted Stock Units (RSUs) 40% Performance Shares (PSAs) 13% Base Salary Incentive-Based Compensation 20% Annual Bonus 2024 CEO Target Pay Mix 87% 2024 All Other NEOs Target Pay Mix 24%
Base Salary Incentive-Based Compensation 20% Annual Bonus 34% Performance Shares (PSAs) 22% Time-Based Restricted Stock Units (RSUs) 76% Executive compensation levels aligned with market Pay mix emphasizes at-risk performance incentives Objective,
measurable, rigorous performance metrics aligned with short- and long-term growth priorities Short- and long-term program payouts capped at 150% Double-trigger change-in-control equity vesting Stock ownership guidelines and holding requirements for
executives and directors Clawback policy applicable to both cash and equity awards Robust anti-hedging and anti-pledging policies No supplemental retirement benefits
![Slide 13 Slide 13](https://www.sec.gov/Archives/edgar/data/1577916/000119312524178054/g845199ex99_1s13g1.jpg)
Performance Metrics Designed to
Drive Top- and Bottom-Line Growth Fiscal 2024/2025 Program Highlights Consistency in weighting: Aggregate of financial measures total 60% Collective strategic measures total 40% Determine strategic measures on an annual basis Added Free Cash Flow
metric in fiscal 2024 based on shareholder feedback Annual Cash Incentives Long-Term Incentives 60% PSAs 40% RSUs Performance Metrics 20% | Adj. EBITDA 20% | Revenue 20% | Free Cash Flow 40% | Strategic Measures Performance Metrics / Terms 3Y
Adjusted EPS| 3Y cliff vest 3Y Ratable vesting Fiscal 2024/2025 Program Highlights Introduced 3-year ratable vesting for RSUs in fiscal 2024 Measures for fiscal 2025 PSAs are currently under review
![Slide 14 Slide 14](https://www.sec.gov/Archives/edgar/data/1577916/000119312524178054/g845199ex99_1s14g1.jpg)
Sustainability Practices Core to
Strategy Ethics and Compliance Strong corporate governance and ethically responsible behavior Our People and Culture “People First Growth Mindset” and resilient human capital management promotes engagement and retention Improving
Community Health Enhancing health outcomes and lowering costs for communities Responsible Supply Chain Committed to a high quality, resilient and sustainably supply chain Environmental Stewardship Prioritizing responsible stewardship to create a
healthy planet Continued achievement of 100% employee completion of our compliance education courses including anti-corruption and human trafficking, fraud, waste and abuse, and Health Insurance Portability and Accountability Act (HIPAA). 2024
World’s Most Ethical Companies® Honoree by Ethisphere (17th consecutive year) DEIB (Diversity, Equity, Inclusion and Belonging) strategic pillars are designed to guide, accelerate and measure how we provide health and wellness solutions
to an increasingly diverse world. Designated one of America’s Greatest Workplaces for Diversity in 2024 by Newsweek Our ONE PREMIER Growth Mindset initiative is designed to intentionally enhance our culture of high performing individuals and
teams by focusing on self-mastery, “real-talk” communication, and multi-level trust. Bi-annual, “People First” employee engagement survey conducted by an independent third-party firm to provide real-time actionable insights,
with [latest] survey showing engagement score of 77, exceeding the global benchmark of 74. 14% turnover rate in CY2023 and retained 93% of high performers in the CY. Administered a substance use disorder program to help provide an accessible,
equitable solution addressing behavioral and physical health needs. Launched Health Equity Collaborative to support our members in meeting and exceeding new regulatory and payer requirements. Partnered with Henry Ford Health to lead screening exams
for adults with diabetes experiencing inequities. Monitored quality, safety and value standards of supplier products and services with ongoing advice and oversight from 29 strategic sourcing committees representing approximately 150 of our U.S.
hospital members. Pioneered the development of supplier contracting standards for assessing and promoting the cybersecurity of internet-connected medical devices and equipment. Annual social responsibility audits of contracted manufacturers by
international third-party auditor All suppliers required to abide by Healthcare Group Purchasing Industry Code of Conduct Completed baseline greenhouse gas (GHG) emissions, calculating Scope 1 and Scope 2 emissions. Completed initial alignment
aligning with the recommendations of the Task Force on Climate-related Financial Disclosures (TCFD). Continued to improve the data collection from our property managers to enhance our GHG assessments and better understand the impact of electricity
and gas consumption at our facilities. Note: Figures presented as of May 31, 2024. * Includes full-time employees who self-identify as either Native Hawaiian, Pacific Islander, American Indian, Alaskan Native, or as being of two or more races
Premier’s 2023 Sustainability Report Gender (% of Workforce*) 54% Female 46% Male
v3.24.2
X |
- DefinitionBoolean flag that is true when the XBRL content amends previously-filed or accepted submission.
+ References
+ Details
Name: |
dei_AmendmentFlag |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionFor the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.
+ References
+ Details
Name: |
dei_DocumentPeriodEndDate |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:dateItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.
+ References
+ Details
Name: |
dei_DocumentType |
Namespace Prefix: |
dei_ |
Data Type: |
dei:submissionTypeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionAddress Line 1 such as Attn, Building Name, Street Name
+ References
+ Details
Name: |
dei_EntityAddressAddressLine1 |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- Definition
+ References
+ Details
Name: |
dei_EntityAddressCityOrTown |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCode for the postal or zip code
+ References
+ Details
Name: |
dei_EntityAddressPostalZipCode |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the state or province.
+ References
+ Details
Name: |
dei_EntityAddressStateOrProvince |
Namespace Prefix: |
dei_ |
Data Type: |
dei:stateOrProvinceItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityCentralIndexKey |
Namespace Prefix: |
dei_ |
Data Type: |
dei:centralIndexKeyItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionIndicate if registrant meets the emerging growth company criteria.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityEmergingGrowthCompany |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionCommission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.
+ References
+ Details
Name: |
dei_EntityFileNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:fileNumberItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTwo-character EDGAR code representing the state or country of incorporation.
+ References
+ Details
Name: |
dei_EntityIncorporationStateCountryCode |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarStateCountryItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityRegistrantName |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionThe Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b-2
+ Details
Name: |
dei_EntityTaxIdentificationNumber |
Namespace Prefix: |
dei_ |
Data Type: |
dei:employerIdItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionLocal phone number for entity.
+ References
+ Details
Name: |
dei_LocalPhoneNumber |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:normalizedStringItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 13e -Subsection 4c
+ Details
Name: |
dei_PreCommencementIssuerTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 14d -Subsection 2b
+ Details
Name: |
dei_PreCommencementTenderOffer |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTitle of a 12(b) registered security.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection b
+ Details
Name: |
dei_Security12bTitle |
Namespace Prefix: |
dei_ |
Data Type: |
dei:securityTitleItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionName of the Exchange on which a security is registered.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Number 240 -Section 12 -Subsection d1-1
+ Details
Name: |
dei_SecurityExchangeName |
Namespace Prefix: |
dei_ |
Data Type: |
dei:edgarExchangeCodeItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Exchange Act -Section 14a -Number 240 -Subsection 12
+ Details
Name: |
dei_SolicitingMaterial |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionTrading symbol of an instrument as listed on an exchange.
+ References
+ Details
Name: |
dei_TradingSymbol |
Namespace Prefix: |
dei_ |
Data Type: |
dei:tradingSymbolItemType |
Balance Type: |
na |
Period Type: |
duration |
|
X |
- DefinitionBoolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.
+ ReferencesReference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Securities Act -Number 230 -Section 425
+ Details
Name: |
dei_WrittenCommunications |
Namespace Prefix: |
dei_ |
Data Type: |
xbrli:booleanItemType |
Balance Type: |
na |
Period Type: |
duration |
|
Premier (NASDAQ:PINC)
過去 株価チャート
から 8 2024 まで 9 2024
Premier (NASDAQ:PINC)
過去 株価チャート
から 9 2023 まで 9 2024